Use of Arctostaphylos uva-ursi Extracts for the Treatment of Urinary Tract Infections

Extracts of the low-lying shrub Arctostaphylos uva-ursi, which is commonly referred to as “bearberry” or simply as Uva ursi, have been widely promoted and frequently used as an herbal treatment for urinary tract infections. These extracts contain a wide range of organic chemicals such as arbutin (4-hydroxyphenyl-β-D-glucopyranoside), polyphenolic compounds, and flavonoids. Arctostaphylos uva-ursi extracts have been shown to inhibit the growth of uropathogenic Gram-negative bacteria. These include Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, and Klebsiella pneumoniae. They also inhibit Gram-positive bacteria such as Staphylococcus aureus and Staphylococcus saprophyticus, and the pathogenic yeast Candida albicans. This review article summarizes the experimental work on the inhibition of microbial growth by Uva ursi extracts and their components. It describes the complementary studies on the effects of these extracts on two key virulence factors, the enzyme urease and the ability of the microbes to form biofilms. The article also reviews the antioxidant and anti-inflammatory properties of these extracts and their effects on other host functions. The preliminary animal and human studies with Arctostaphylos uva-ursi extracts are summarized, as are the human clinical trials that have been completed so far. These studies have shown that these extracts are relatively safe, although the key component arbutin can be metabolized to form the more toxic compound hydroquinone. Although the laboratory data indicate that Uva ursi preparations can effectively inhibit urinary tract pathogens and so may represent an alternative to traditional antibiotics, the clinical studies are far more limited and currently insufficient to justify their widespread medical use. Further areas of research might include the use of extracts from plants with low arbutin contents or the combination of Arctostaphylos uva-ursi extracts with those from other plants.

Authors

Institutions

Publication Details

Journal
European Journal of Medicinal Plants
Published
2025-05-02
DOI
https://doi.org/10.9734/ejmp/2025/v36i31264
Citations
2
Primary Topic
Phytochemistry and Biological Activities
Type
article
Field-Weighted Citation Impact
3.50
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of Arctostaphylos uva-ursi Extracts for the Treatment of Urinary Tract Infections

Charles E. Deutch
2 citations
European Journal of Medicinal Plants
Phytochemistry and Biological Activities
3.50
article

Use of Arctostaphylos uva-ursi Extracts for the Treatment of Urinary Tract Infections

Charles E. Deutch
article en
2 citations

Abstract

Extracts of the low-lying shrub Arctostaphylos uva-ursi, which is commonly referred to as “bearberry” or simply as Uva ursi, have been widely promoted and frequently used as an herbal treatment for urinary tract infections. These extracts contain a wide range of organic chemicals such as arbutin (4-hydroxyphenyl-β-D-glucopyranoside), polyphenolic compounds, and flavonoids. Arctostaphylos uva-ursi extracts have been shown to inhibit the growth of uropathogenic Gram-negative bacteria. These include Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, and Klebsiella pneumoniae. They also inhibit Gram-positive bacteria such as Staphylococcus aureus and Staphylococcus saprophyticus, and the pathogenic yeast Candida albicans. This review article summarizes the experimental work on the inhibition of microbial growth by Uva ursi extracts and their components. It describes the complementary studies on the effects of these extracts on two key virulence factors, the enzyme urease and the ability of the microbes to form biofilms. The article also reviews the antioxidant and anti-inflammatory properties of these extracts and their effects on other host functions. The preliminary animal and human studies with Arctostaphylos uva-ursi extracts are summarized, as are the human clinical trials that have been completed so far. These studies have shown that these extracts are relatively safe, although the key component arbutin can be metabolized to form the more toxic compound hydroquinone. Although the laboratory data indicate that Uva ursi preparations can effectively inhibit urinary tract pathogens and so may represent an alternative to traditional antibiotics, the clinical studies are far more limited and currently insufficient to justify their widespread medical use. Further areas of research might include the use of extracts from plants with low arbutin contents or the combination of Arctostaphylos uva-ursi extracts with those from other plants.

European Journal of Medicinal PlantsVol. 36(3)
Arizona State University (US)
Openalex Percentile: Top 9%
Phytochemistry and Biological Activities
3.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Use of Arctostaphylos uva-ursi Extracts for the Treatment of Urinary Tract Infections — Charles E. Deutch · European Journal of Medicinal Plants (2025) | TGRS Research Map | TGRS